Biodexa Pharmaceuticals Announces Plan to Offer 1.28 Billion Shares from Holders
Monday, 18 March 2024, 20:46
Biodexa Pharmaceuticals Shareholder Activity
Biodexa Pharmaceuticals is planning a substantial offering of 1.28 billion shares held by its current stakeholders. This action will significantly influence the company's ownership landscape and potentially shift control within the organization.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.